LAMICTAL Safety Questions, LAMICTAL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LAMICTAL. Our extensive database of LAMICTAL adverse events and LAMICTAL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LAMICTAL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




LAMICTAL Safety Reports

Total LAMICTAL reports: 2391.
LAMICTAL FDA safety alerts: 2001 2006 .
Reported deaths: 73    Reported hospitalizations: 522.
Take LAMICTAL Side Effects Survey or Share Your LAMICTAL Story. LAMICTAL Usage.

Showing 1-75 of 2391 Next >

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Jan 31, 2007. Female patient, 47 years of age, weighting 230.4 lb, was diagnosed with pain and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: meningitis. LAMICTAL dosage: 25MG SINGLE DOSE. During the same period patient was treated with DETROL, WELLBUTRIN, ATIVAN, ZOLOFT, LITHIUM CARBONATE, PERCOCET, COPAXONE, AMBIEN. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Physician from GERMANY on Jan 29, 2007. Male patient, 28 years of age, weighting 213.8 lb, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: convulsion. LAMICTAL dosage: unknown. During the same period patient was treated with DIAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 05, 2007. Female patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: amnesia, arthralgia, confusional state, convulsion, depression, disorientation, disturbance in attention, dizziness, mental disorder. LAMICTAL dosage: 750MG PER DAY. During the same period patient was treated with KEPPRA, DILANTIN, KLONOPIN, DURICEF, EVISTA, ZONEGRAN, VITAMIN CAP. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Health Professional from UNITED STATES on Jan 26, 2007. Female patient, 69 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: affect lability, anxiety, feeling jittery, insomnia, loss of consciousness, transient ischaemic attack. LAMICTAL dosage: 300MG PER DAY. During the same period patient was treated with VIVELLE, BENICAR, LOZOL, CALCIUM, VITAMINS, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 02, 2007. Male patient was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: pyrexia, respiratory distress. LAMICTAL dosage: 50MG PER DAY. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2007. Female patient was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: erythema, nasopharyngitis, pyrexia. LAMICTAL dosage: 12.5MG PER DAY. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 01, 2007. Female patient, 19 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: pleural effusion, systemic lupus erythematosus. LAMICTAL dosage: 200MG TWICE PER DAY. Patient was hospitalized and became disabled. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from SWEDEN on Jan 30, 2007. Female patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: congenital hepatobiliary anomaly. LAMICTAL dosage: 500MG PER DAY. Patient recovered.

Physician from GERMANY reported LAMICTAL problem on Jan 31, 2007. Female patient was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: psoriasis. LAMICTAL dosage: 100MG PER DAY. During the same period patient was treated with ERGENYL. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 23, 2007. Female patient, 18 years of age, was diagnosed with obesity and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: convulsion. LAMICTAL dosage: unknown. During the same period patient was treated with ORLISTAT. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported LAMICTAL problem on Feb 02, 2007. Male patient, 45 years of age, weighting 136.7 lb, was diagnosed with grand mal convulsion and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, skin laceration. LAMICTAL dosage: 100MG TWICE PER DAY. During the same period patient was treated with PHENHYDAN, MAGNESIUM. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2007. Female patient, 29 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, uterine dilation and curettage, vaginal haemorrhage. LAMICTAL dosage: 600MG PER DAY. During the same period patient was treated with PRENATAL VITAMINS, FOLIC ACID. Patient recovered.

Health Professional from UNITED KINGDOM reported LAMICTAL problem on Jan 31, 2007. Female patient, 29 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: convulsion, vaginal inflammation, vaginal pain, vaginal swelling. LAMICTAL dosage: unknown. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2007. Female patient, 28 years of age, weighting 180.0 lb, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: oral soft tissue disorder, pain, pyrexia, rash, swollen tongue. LAMICTAL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 06, 2007. Female patient was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: autoimmune thyroiditis, basedow's disease, keratoconjunctivitis sicca. LAMICTAL dosage: 200MG PER DAY. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from AUSTRALIA on Jan 30, 2007. Male patient, child 9 years of age, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: aggression. LAMICTAL dosage: unknown. During the same period patient was treated with KEPPRA, FISH OIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 07, 2007. Female patient, 17 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, cardiac arrest, circulatory collapse, convulsion, overdose, pleural effusion, pulmonary haemorrhage, pulse absent, sinus tachycardia. LAMICTAL dosage: unknown. During the same period patient was treated with WELLBUTRIN, AMPHETAMINE, BENZODIAZEPINES, MARIJUANA. Patient was hospitalized and became disabled. Patient recovered.

LAMICTAL problem was reported by a Physician from FRANCE on Jan 31, 2007. Female patient, 86 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: epilepsy, hyponatraemia, inappropriate antidiuretic hormone secretion. LAMICTAL dosage: unknown. During the same period patient was treated with GARDAN, NORSET. Patient recovered.

Pharmacist from FRANCE reported LAMICTAL problem on Jan 30, 2007. Female patient, 29 years of age, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: convulsion, weight increased. LAMICTAL dosage: 200MG PER DAY. During the same period patient was treated with PAROXETINE. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from BELGIUM on Jan 24, 2007. Male patient, 48 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, epilepsy, parkinson's disease. LAMICTAL dosage: unknown. During the same period patient was treated with GABAPENTIN, VALPROATE. Patient recovered.

Physician from LEBANON reported LAMICTAL problem on Feb 02, 2007. Female patient, 26 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: hypotonia, restlessness, vision blurred. LAMICTAL dosage: unknown. During the same period patient was treated with DEPAKENE. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Male patient was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood electrolytes abnormal, blood potassium decreased, syncope. LAMICTAL dosage: 450MG TWICE PER DAY. During the same period patient was treated with CARBAMAZEPINE. Patient was hospitalized. Patient recovered.

Physician from NEW ZEALAND reported LAMICTAL problem on Feb 06, 2007. Female patient, 49 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, globulins increased, hepatic enzyme increased, jaundice, yellow skin. LAMICTAL dosage: 200MG TWICE PER DAY. During the same period patient was treated with PARACETAMOL, VITAMIN CAP. Patient recovered.

LAMICTAL problem was reported by a Physician from AUSTRALIA on Feb 05, 2007. Female patient, child 9 years of age, weighting 75.40 lb, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: aggression, agitation. LAMICTAL dosage: unknown. During the same period patient was treated with KEPPRA, FISH OIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 09, 2007. Female patient, 81 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: amnesia, arthralgia, confusional state, convulsion, depression, disorientation, disturbance in attention, dizziness, fatigue. LAMICTAL dosage: 750MG PER DAY. During the same period patient was treated with KEPPRA, DILANTIN, KLONOPIN, DURICEF, EVISTA, ZONEGRAN, VITAMIN CAP. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Female patient, child 12 years of age, weighting 89.29 lb, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: hepatic failure, rash. LAMICTAL dosage: 12.5MG PER DAY. During the same period patient was treated with ADDERALL, RISPERDAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 12, 2007. Female patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: anorexia, diarrhoea, fatigue, hypokalaemia, lethargy, malaise, pyrexia, rash, stevens-johnson syndrome. LAMICTAL dosage: 200MG VARIABLE DOSE. During the same period patient was treated with FELBAMATE, GEODON, ZOLOFT, KLONOPIN, PROPRANOLOL, VITAMIN B6, FOLIC ACID, CEFTIN. Patient recovered.

LAMICTAL problem was reported by a Physician from SPAIN on Feb 12, 2007. Female patient, 22 years of age, was diagnosed with bipolar ii disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: coordination abnormal. LAMICTAL dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, QUETIAPINE FUMARATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 14, 2007. Male patient, 64 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage, arthralgia, fatigue, headache, myalgia, performance status decreased. LAMICTAL dosage: 100MG TWICE PER DAY. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from TURKEY on Jan 31, 2007. Female patient, 24 years of age, was diagnosed with complex partial seizures and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, condition aggravated, convulsion, leukopenia. LAMICTAL dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, BARBEXACLONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 13, 2007. Male patient, 14 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: musculoskeletal stiffness, suicidal ideation. LAMICTAL dosage: 150MG PER DAY. During the same period patient was treated with SEROQUEL, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Male patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: encephalopathy. LAMICTAL dosage: 150MG TWICE PER DAY. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMICTAL problem on Feb 08, 2007. Female patient, 42 years of age, weighting 132.3 lb, was diagnosed with depression and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, hallucination, visual, headache, hyperacusis, nightmare, sleep disorder. LAMICTAL dosage: unknown. During the same period patient was treated with CITALOPRAM. Patient recovered.

LAMICTAL problem was reported by a Health Professional from GERMANY on Feb 13, 2007. Female patient, 23 years of age, weighting 127.9 lb, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: asthenia, depressed level of consciousness, intentional overdose, suicide attempt. LAMICTAL dosage: unknown. During the same period patient was treated with ADDERALL, AMBIEN, TOPAMAX, VALIUM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 12, 2007. Male patient, weighting 68.00 lb, was diagnosed with myoclonic epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. LAMICTAL dosage: 100MG BID PO. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2007. Female patient, 37 years of age, weighting 130.3 lb, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: cellulitis, impetigo, pain, rash, rash vesicular. LAMICTAL dosage: unknown. During the same period patient was treated with LUNESTA, EFFEXOR, ORAL CONTRACEPTIVE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 14, 2007. Male patient was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder, malaise, stevens-johnson syndrome. LAMICTAL dosage: 25MG TWICE PER DAY. During the same period patient was treated with GEODON. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2007. Female patient, 49 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: deafness, ear pain, lip pain, rash. LAMICTAL dosage: 200MG PER DAY. During the same period patient was treated with LITHIUM CARBONATE, CLONAZEPAM, RISPERDAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 16, 2007. Female patient, 35 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: nausea, rash, vomiting. LAMICTAL dosage: unknown. During the same period patient was treated with GEODON, TRILEPTAL. Patient recovered.

LAMICTAL problem was reported by a Health Professional from UNITED STATES on Feb 16, 2007. Male patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: dermoid cyst. LAMICTAL dosage: 200MG PER DAY. Patient recovered.

Physician from CHINA reported LAMICTAL problem on Feb 14, 2007. Male patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative, overdose. LAMICTAL dosage: 50MG PER DAY. During the same period patient was treated with VALPROATE. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 15 years of age, weighting 155.4 lb, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: blister, corneal abrasion, eye pruritus, oral mucosal blistering, rash. LAMICTAL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 20, 2007. Female patient, 19 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, pleural effusion, systemic lupus erythematosus. LAMICTAL dosage: 200MG TWICE PER DAY. Patient was hospitalized and became disabled. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2007. Female patient, 54 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: breast cancer. LAMICTAL dosage: 200MG TWICE PER DAY. During the same period patient was treated with NEURONTIN, SYNTHROID, BREWERS YEAST, GARLIC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 20, 2007. Male patient, child 11 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, depressed level of consciousness, muscular weakness. LAMICTAL dosage: 10MG TWICE PER DAY. During the same period patient was treated with DEPAKOTE. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Health Professional from NEW ZEALAND on Feb 15, 2007. Female patient, child 9 years of age, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, amnesia, dissociation, emotional disorder, headache, insomnia. LAMICTAL dosage: unknown. During the same period patient was treated with TEGRETOL, EPILIM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 22, 2007. Male patient, 59 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: abasia, disturbance in attention, eating disorder, eye swelling, immune system disorder, increased viscosity of bronchial secretion, malaise, mouth ulceration, pain. LAMICTAL dosage: 100MG PER DAY. During the same period patient was treated with PROZAC, CONCERTA. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Physician from ARGENTINA on Feb 21, 2007. Female patient, 25 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: asthenia, pain, pallor, pancytopenia. LAMICTAL dosage: 350MG PER DAY. Patient recovered.

Physician from FRANCE reported LAMICTAL problem on Feb 13, 2007. Male patient was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: cyst, dyskinesia, moaning. LAMICTAL dosage: 200MG TWICE PER DAY. During the same period patient was treated with URBANYL, DEPAKENE. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Female patient, 15 years of age, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, eye irritation, feeling abnormal, ill-defined disorder, trismus. LAMICTAL dosage: 50MG TWICE PER DAY. During the same period patient was treated with TRILEPTAL. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported LAMICTAL problem on Feb 20, 2007. Male patient, 29 years of age, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: jaundice. LAMICTAL dosage: unknown. During the same period patient was treated with CLONAZEPAM. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from NETHERLANDS on Feb 19, 2007. Male patient, 54 years of age, weighting 165.3 lb, was diagnosed with benign prostatic hyperplasia and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: epilepsy. LAMICTAL dosage: 100MG PER DAY. During the same period patient was treated with XATRAL, KEPPRA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 23, 2007. Female patient, 66 years of age, was diagnosed with depression and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: asthma, chest pain, confusional state, headache, insomnia, nausea, palpitations, pruritus, rash. LAMICTAL dosage: 25MG PER DAY. During the same period patient was treated with DYCLONINE, PROZAC, DILANTIN, ALBUTEROL. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from HONG KONG on Feb 22, 2007. Female patient was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: pneumonia streptococcal, pyrexia. LAMICTAL dosage: 100MG PER DAY. During the same period patient was treated with LITHIUM CARBONATE, SEROQUEL. Patient recovered.

Physician from SWITZERLAND reported LAMICTAL problem on Feb 21, 2007. Female patient, 20 years of age, weighting 119.0 lb, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: blister, conjunctivitis, coombs negative haemolytic anaemia, dysphagia, lip erosion, mouth plaque, mucous membrane disorder, pharyngitis, post inflammatory pigmentation change. LAMICTAL dosage: unknown. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient recovered.

LAMICTAL problem was reported by a Physician from GERMANY on Feb 23, 2007. Male patient, 13 years of age, weighting 125.7 lb, was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, gilbert's syndrome, nausea, ocular icterus, vomiting. LAMICTAL dosage: 5MG TWICE PER DAY. During the same period patient was treated with ORFIRIL LONG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on June 07, 2006. Female patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: depression, insomnia, rash erythematous. LAMICTAL dosage: 150MG TWICE PER DAY. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Female patient, 46 years of age, was diagnosed with affective disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, asthenia, bone pain, bunion, hair growth abnormal, headache, rash, tinnitus. LAMICTAL dosage: 50MG TWICE PER DAY. During the same period patient was treated with NEURONTIN, KLONOPIN, CELEXA, RITALIN, CYMBALTA, LEXAPRO, WELLBUTRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Feb 27, 2006. Female patient, 35 years of age, was diagnosed with bipolar disorder, sleep disorder, anxiety and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: acne, anger, back pain, dizziness, elevated mood, euphoric mood, glossitis, irritability, musculoskeletal pain. LAMICTAL dosage: 25MG PER DAY. During the same period patient was treated with XANAX, PROZAC, TYLENOL, RISPERDAL, TEMAZEPAM. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2006. Female patient, 26 years of age, was diagnosed with bipolar disorder, anxiety, depression, contraception and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: pregnancy. LAMICTAL dosage: 100MG PER DAY. During the same period patient was treated with SEROQUEL, EFFEXOR, BIRTH CONTROL S. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Jan 13, 2006. Male patient, 57 years of age, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: accidental overdose, arthritis, balance disorder, headache. LAMICTAL dosage: 400MG TWICE PER DAY. During the same period patient was treated with CLORAZEPATE. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2006. Male patient, 74 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: mouth ulceration, pruritus, swollen tongue, tongue biting, tongue ulceration. LAMICTAL dosage: unknown. During the same period patient was treated with VASOTEC, POTASSIUM CL, LITHIUM CARBONATE, ASPIRIN, GLUCOPHAGE, AMIODARONE, HYDROCHLOROTHIAZIDE, DYNACIRC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on July 24, 2006. Female patient, 20 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: vision blurred, weight increased. LAMICTAL dosage: 25MG PER DAY. During the same period patient was treated with ORTHO TRI. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Female patient, 44 years of age, was diagnosed with depression and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: musculoskeletal chest pain, therapeutic response unexpected. LAMICTAL dosage: 25MG TWICE PER DAY. During the same period patient was treated with LAMOTRIGINE, ADDERALL, KLONOPIN, PROTONIX, LEXAPRO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on June 27, 2006. Female patient, 43 years of age, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cluster headache, obsessive thoughts, temperature regulation disorder. LAMICTAL dosage: 75MG TWICE PER DAY. During the same period patient was treated with OXYCONTIN, BELLADONA, BECLOVENT, COMPAZINE, PLAQUENIL, VITAMIN B CAP, ALPRAZOLAM. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on May 05, 2006. Male patient, 19 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: rash. LAMICTAL dosage: 50MG PER DAY. During the same period patient was treated with DEPAKOTE, ZYPREXA, FISH OIL, VITAMINS. Patient recovered.

Health Professional from UNITED STATES reported LAMICTAL problem on June 19, 2006. Female patient, 62 years of age, weighting 102.3 lb, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: insomnia, stomach discomfort, weight decreased. LAMICTAL dosage: 150MG PER DAY. During the same period patient was treated with PAROXETINE, PAXIL CR. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2006. Female patient, 49 years of age, weighting 260.6 lb, was diagnosed with bipolar disorder, depression, insomnia, anxiety and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: pruritus. LAMICTAL dosage: 50MG PER DAY. During the same period patient was treated with LEXAPRO, AMBIEN, KLONOPIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on July 20, 2006. Female patient, 57 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: anxiety, burning sensation, migraine, pruritus, rash, retching, swollen tongue, urticaria. LAMICTAL dosage: 300MG PER DAY. During the same period patient was treated with VERSED, MORPHINE. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 03, 2006. Male patient, 35 years of age, weighting 200.4 lb, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: priapism. LAMICTAL dosage: 100MG TWICE PER DAY. During the same period patient was treated with ATIVAN, VICODIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on May 03, 2006. Male patient, 66 years of age, was diagnosed with bipolar disorder, depression and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: chest pain, constipation, libido decreased, myalgia. LAMICTAL dosage: 100MG PER DAY. During the same period patient was treated with WELLBUTRIN. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2006. Female patient, 40 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: muscle twitching, paraesthesia. LAMICTAL dosage: 200MG PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Mar 06, 2006. Female patient, 18 years of age, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, chest discomfort, dizziness, dyspnoea, headache, hyperacusis, insomnia, photophobia, vision blurred. LAMICTAL dosage: 100MG PER DAY. During the same period patient was treated with ZYPREXA, AMBIEN. Patient recovered.

LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2006. Male patient, 48 years of age, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: angioedema. LAMICTAL dosage: 50MG PER DAY. During the same period patient was treated with DEPAKOTE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Mar 09, 2006. Female patient, 46 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: pyrexia. LAMICTAL dosage: 25MG AT NIGHT. During the same period patient was treated with WELLBUTRIN, XANAX. Patient recovered.

Showing 1-75 of 2391 Next >

Ask Our Patient Community about LAMICTAL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab